UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of physiology, ISSN 0022-3751, 08/2010, Volume 588, Issue 15, p. 2691
Journal Article
Tetrahedron, ISSN 0040-4020, 2006, Volume 62, Issue 43, pp. 10248 - 10254
Journal Article
Chemistry & biodiversity, ISSN 1612-1872, 04/2020, Volume 17, Issue 4, pp. e1900696 - n/a
acyloxy | quinidine | insecticidal activity | structural modification | dihydroquinidine | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Insecticides - pharmacology | Moths - growth & development | Quinidine - chemistry | Insecticides - chemistry | Animals | Insecticides - chemical synthesis | Larva - drug effects | Stereoisomerism | Quinidine - analogs & derivatives | Quinidine - pharmacology | Moths - drug effects | Quinidine - chemical synthesis | Natural products | Quinidine | Insecticides | In vivo methods and tests | Bans | Derivatives | Configurations | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 11/2020, Volume 63, Issue 21, pp. 12873 - 12886
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Quinidine - metabolism | Cell Survival - drug effects | DNA Topoisomerases, Type II - metabolism | Quinidine - chemistry | Humans | Quinidine - analogs & derivatives | Half-Life | Quinidine - pharmacology | Topoisomerase II Inhibitors - pharmacology | DNA - metabolism | Topoisomerase II Inhibitors - metabolism | DNA - chemistry | Animals | Topoisomerase II Inhibitors - chemistry | Isoenzymes - metabolism | DNA Topoisomerases, Type II - chemistry | Cell Line, Tumor | Mice | DNA Cleavage | Isoenzymes - antagonists & inhibitors | Drug Screening Assays, Antitumor | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 01/2018, Volume 90, Issue 1, pp. e67 - e72
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Quinidine - blood | Seizures - blood | Epilepsy, Frontal Lobe - blood | Anticonvulsants - blood | Epilepsy, Frontal Lobe - genetics | Seizures - genetics | Double-Blind Method | Humans | Middle Aged | Seizures - drug therapy | Anticonvulsants - therapeutic use | Nerve Tissue Proteins - genetics | Potassium Channels - genetics | Cross-Over Studies | Anticonvulsants - adverse effects | Quinidine - adverse effects | Treatment Failure | Adolescent | Adult | Gain of Function Mutation | Quinidine - therapeutic use | Epilepsy, Frontal Lobe - drug therapy | Precision Medicine
Journal Article
Expert opinion on investigational drugs, ISSN 1354-3784, 01/2017, Volume 26, Issue 1, pp. 121 - 132
AVP-786 | Agitation | quinidine | Alzheimer disease | dementia | AVP-923 | dextromethorphan | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Dextromethorphan - therapeutic use | Quinidine - chemistry | Alzheimer Disease - physiopathology | Brain - physiopathology | Humans | Alzheimer Disease - drug therapy | Deuterium - chemistry | Dextromethorphan - chemistry | Treatment Outcome | Psychomotor Agitation - drug therapy | Randomized Controlled Trials as Topic | Brain - metabolism | Psychomotor Agitation - etiology | Tissue Distribution | Animals | Quinidine - pharmacokinetics | Dextromethorphan - pharmacokinetics | Quinidine - therapeutic use | Drug Combinations | Index Medicus
Journal Article
Movement disorders, ISSN 0885-3185, 06/2017, Volume 32, Issue 6, pp. 893 - 903
levodopa‐induced dyskinesia | Parkinson's disease | AVP‐923 | Unified Dyskinesia Rating Scale | dextromethorphan/quinidine | levodopa-induced dyskinesia | AVP-923 | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Outcome Assessment (Health Care) | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Enzyme Inhibitors - administration & dosage | Dyskinesia, Drug-Induced - drug therapy | Quinidine - adverse effects | Female | Dextromethorphan - adverse effects | Drug Therapy, Combination | Excitatory Amino Acid Antagonists - adverse effects | Dyskinesia, Drug-Induced - etiology | Dextromethorphan - pharmacology | Double-Blind Method | Enzyme Inhibitors - pharmacology | Excitatory Amino Acid Antagonists - administration & dosage | Excitatory Amino Acid Antagonists - pharmacology | Quinidine - pharmacology | Quinidine - administration & dosage | Antiparkinson Agents - adverse effects | Cross-Over Studies | Pilot Projects | Levodopa - adverse effects | Aged | Dextromethorphan - administration & dosage | Medicine, Experimental | Medical research | Dopa | Analysis | Movement disorders | Index Medicus
Journal Article
The veterinary journal (1997), ISSN 1090-0233, 02/2021, Volume 268
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 09/2017, Volume 25, Issue 17, pp. 4656 - 4664
Liver microsomal stability | Bioisostere | Inflammatory pain | T-type calcium channel | 3,4-Dihydroquinazoline | Cytotoxic activity | Quinazolines - chemical synthesis | Quinidine - chemistry | Quinidine - toxicity | Humans | Microsomes, Liver - metabolism | Quinidine - analogs & derivatives | Calcium Channels, T-Type - metabolism | Analgesics - chemical synthesis | Calcium Channels, T-Type - chemistry | HEK293 Cells | Inhibitory Concentration 50 | Calcium Channels, T-Type - genetics | Quinazolines - chemistry | Quinidine - chemical synthesis | Calcium Channel Blockers - chemical synthesis | A549 Cells | Cell Survival - drug effects | Drug Stability | Rats | Analgesics - toxicity | Calcium Channel Blockers - toxicity | Patch-Clamp Techniques | Animals | Quinazolines - toxicity | Analgesics - chemistry | Calcium Channel Blockers - chemistry | Fluorine - chemistry | Medical colleges | Calcium channels | Analysis | Liver | Resveratrol | Research institutes | Lung cancer, Non-small cell | Index Medicus
Journal Article
Nuclear medicine and biology, ISSN 0969-8051, 2013, Volume 40, Issue 6, pp. 764 - 775
Radiology | P-glycoprotein | [11C]quinidine | Positron emission tomography | [11C]laniquidar | Epilepsy | C]laniquidar | C]quinidine | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Phenobarbital - pharmacology | Quinidine - blood | Quinidine - chemistry | Quinolines - blood | Recurrence | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Epilepsy - diagnostic imaging | Epilepsy - metabolism | Male | Quinolines - pharmacology | Radiochemistry | Female | Disease Models, Animal | Quinidine - metabolism | Quinolines - chemistry | Gene Expression Regulation | Rats | Treatment Outcome | Benzazepines - blood | Positron-Emission Tomography - methods | Rats, Sprague-Dawley | Quinolines - metabolism | Phenobarbital - therapeutic use | Animals | Epilepsy - drug therapy | Quinolines - therapeutic use | Benzazepines - metabolism | Kinetics | Benzazepines - chemistry | Chronic Disease | Carbon Radioisotopes | Epilepsy - blood | PET imaging | Index Medicus
Journal Article
Annals of neurology, ISSN 0364-5134, 12/2015, Volume 78, Issue 6, pp. 995 - 999
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Enzyme Inhibitors - pharmacology | Child, Preschool | Male | Quinidine - pharmacology | Quinidine - administration & dosage | Nerve Tissue Proteins - genetics | Drug Resistant Epilepsy - drug therapy | Potassium Channels - genetics | Enzyme Inhibitors - administration & dosage | Drug Resistant Epilepsy - genetics | Female | Mutation | Child | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 09/2019, Volume 171, Issue 5, pp. 362 - 363
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Malaria, Falciparum - drug therapy | Artesunate - therapeutic use | United States | Humans | Quinidine - analogs & derivatives | Male | Antimalarials - therapeutic use | Drug Approval | Young Adult | Patient Care Planning | Malaria, Falciparum - diagnosis | Quinidine - supply & distribution | Quinidine - therapeutic use | Antimalarials - supply & distribution | United States Food and Drug Administration | Prescription drugs | Hospitals | Malaria | Medical treatment | Public health | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 12/2011, Volume 339, Issue 3, pp. 935 - 944
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Erlotinib Hydrochloride | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Quinazolines - pharmacokinetics | Male | Neoplasm Proteins - metabolism | Antineoplastic Agents - metabolism | Brain - metabolism | Biological Transport, Active | Quinazolines - metabolism | Quinidine - pharmacokinetics | ATP-Binding Cassette Transporters - metabolism | Female | Antineoplastic Agents - pharmacokinetics | Quinazolines - cerebrospinal fluid | Quinidine - metabolism | Antineoplastic Agents - cerebrospinal fluid | Rats | Blood-Brain Barrier - drug effects | Quinidine - cerebrospinal fluid | Blood-Brain Barrier - metabolism | Mice, Knockout | Brain - drug effects | Animals | Dogs | ATP Binding Cassette Transporter, Sub-Family B - metabolism | Biomarkers | Protein Binding | Mice
Journal Article